References
- Zangari M, Elice F, Fink L, Tricot G. Hemostatic dysfunction in paraproteinemias and amyloidosis. Semin Thromb Hemost 2007; 33: 339–349
- Okajima K, Kohno I, Soe G, Okabe H, Takatsuki K, Binder B R. Direct evidence for systemic fibrinogenolysis in patients with acquired alpha 2-plasmin inhibitor deficiency. Am J Hematol 1994; 45: 16–24
- Bouma B, Maas C, Hazenberg B P, Lokhorst H M, Gebbink M F. Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses. J Thromb Haemost 2007; 5: 1139–1142
- Sane D C, Pizzo S V, Greenberg C S. Elevated urokinase-type plasminogen activator level and bleeding in amyloidosis: case report and literature review. Am J Hematol 1989; 31: 53–57
- Liebman H A, Carfagno M K, Weitz I C, Berard P, Diiorio J M, Vosburgh E, Simms R W. Excessive fibrinolysis in amyloidosis associated with elevated plasma single-chain urokinase. Am J Clin Pathol 1992; 98: 534–541
- Okajima K, Uchiba M, Murakami K. Nafamostat mesilate. Cardiovasc Drug Rev 1995; 13: 51–65
- Meyer K, Williams E C. Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis. Am J Med 1985; 79: 394–396
- Favier R, Aoki N, deMoerloose P. Congenital inhibitor deficiencies: a review. Br J Haematol 2001; 114: 4–10
- Uprichard J, Perry D J. Factor X deficiency. Blood Rev 2002; 16: 97–110
- Peyvandi F, Cattaneo M, Inbal A, DeMoerloose P, Spreafico M. Rare bleeding disorders. Haemophilia 2008; 14: 202–210
- Sahu S, Nageswari K, Banerjee R, Puniyani R R. Hemorheological changes in nephrotic syndrome. Clin Hemorheol Microcirc 1998; 19: 17–20
- Katzmann J A, Abraham R S, Dispenzieri A, Lust J A, Kyle R A. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Clin Chem 2005; 51: 878–881
- Hjertner O, Qvigstad G, Hjorth-Hansen H, Seidel C, Woodliff J, Epstein J, Waage A, Sundan A, Börset M. Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells. Br J Haematol 2000; 10: 815–822
- Davis J, Wagner M R, Zhang W, Xu F, Van Nostrand W E. Amyloid beta-protein stimulates the expression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in human cerebrovascular smooth muscle cells. J Biol Chem 2003; 278: 19054–19061
- Makino D L, Henschen-Edman A H, Larson S B, McPherson A. Bence Jones KWR protein structures determined by X-ray crystallography. Acta Crystallogr D Biol Crystallogr 2007; 63: 780–792
- Griffiths R W, Gleich G J. Proteolytic degradation of IgD and its relation to molecular conformation. J Biol Chem 1972; 247: 4543–4548
- Page L J, Suk J Y, Huff M E, Lim H J, Venable J, Yates J, Kelly J W, Balch W E. Metalloendoprotease cleavage triggers gelsolin amyloidogenesis. EMBO J 2005; 24: 4124–4132